A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Trial Profile

A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy

Completed
Phase of Trial: Phase II

Latest Information Update: 22 May 2017

At a glance

  • Drugs ARRY 797 (Primary)
  • Indications Dilated cardiomyopathy
  • Focus Therapeutic Use
  • Sponsors Array BioPharma
  • Most Recent Events

    • 30 Aug 2016 Results published in Array BioPharma media release.
    • 01 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 03 May 2016 Results from this trial will be presented at the European Society of Cardiology, according to an Array BioPharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top